| HOME >> BIOLOGY >> TECHNOLOGY |
$
250,383$
,211,561Accrued salaries and benefits
432,052563,706Deferred revenue
68,442170,641Total current liabilities
750,8771,945,908Deferred compensation
-550,000Deferred rent
56,27680,945Total liabilities
807,1532,576,853Commitments and contingencies
--Stockholders' equityPreferred stock, $0.01 par value, 2,000,000 shares authorized;5,250 series B issued and 1 outstanding at September 30, 2011and December 31, 2010
--Common stock, $0.01 par value, 5,000,000 shares authorized; 2,570,531 and 2,143,631 issued, 2,562,488 and 2,135,588outstanding at September 30, 2011 and December 31, 2010,respectively
25,70521,436Paid-in capital in excess of par value
41,109,89438,568,814Treasury stock, 8,043 shares, at cost at September 30, 2011and December 31, 2010
(464,786)(464,786)Accumulated deficit
(35,847,638)(33,685,245)Total stockholders' equity
4,823,1754,440,219Total liabilities and stockholders' equity
$
5,630,328$
7,017,072
'/>"/>
| SOURCE Spherix Incorporated Copyright©2010 PR Newswire. All rights reserved |